TITLE GOES HERE...

CAMBRIDGE, Mass., Sept. xx, 20xx – Axcella Health, a biotechnology company pioneering Defined Amino Acid Compositions (DAACS™) as therapeutics across a range of important diseases, announced today.......

About Axcella Health

Axcella has pioneered a new therapeutic class – Defined Amino Acid Compositions (DAACs™). Our DAAC Therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. With our Axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. This platform has delivered a rich pipeline including clinical programs in liver, metabolic, CNS and orphan diseases. www.axcellahealth.com

Media Contact
Stefanie Tuck
MacDougall Biomedical Communications
stuck@macbiocom.com
781-235-3060

Company Contact
Ivana Magovčević-Liebisch
iliebisch@axcellahealth.com
857-320-2204